Year: 2008
Type: dissertation
Study design: Observational Study
Abstract: COPD (Chronic Obstructive Pulmonary Disease) worldwide has a prevalence of\n10% in men and 8.5% in women. Exacerbations of COPD account for\napproximately 10% of all acute medical admissions. Projected prevalence\nfigures suggest that by 2020 COPD will be the third leading cause of mortality\nworldwide thus imposing a significant burden on healthcare resources in the\nfuture. Acute exacerbations are not only responsible for a decline in the\npatient’s quality of life, but have a major socioeconomic impact. Following a\npilot study that showed current smokers recover lung function much more\nslowly from their exacerbation than ex smokers, I initiated a properly powered\nprospective study to investigate the difference between the two groups.\n\nA total of 58 patients admitted with acute infectious exacerbations of COPD\nwere recruited to the study to determine the effect of smoking status on their\nexacerbation. Throughout the admission lung function was measured. Sputum\nwas cultured for bacteria, and PCR used to detect viral infection. Blood and\nsputum cells were analyzed by flow cytometry. Serum was collected for CRP\nlevels.\n\nEx-smokers recovered significantly more quickly than current smokers in all\nspirometric parameters (P<0.01), and were discharged sooner (mean 3.08 vs\n5.59 days, P<0.001). Sputum culture was positive for more pathogenic bacteria\nin current smokers, especially H. influenzae, which was associated with a\nsignificantly higher CRP rise (p<0.05) than any other organism. CD8+ T cells\npredominated in the sputum of ex-smokers while CD4+ T cells were the\ndominant cell type in current smokers (p<0.01).\n\nCurrent smoking is a risk factor for more severe exacerbations, delayed\nrecovery and prolonged hospitalization. This may result from a variety of factors\nincluding bacterial, immune mediated responses and systemic inflammation.
Author: Simon Bourne
Institution: University of Southampton
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W659528160
